(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INDIANA BLOODWORX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

INDIANA BLOODWORX

ST13

US500000097979307

Class

35, 44

Filing

97979307

Registration

7645514

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

01/07/2025

Classification

Registered

Trademark type

Word

Nice classes

35, 44

Filing date

08/25/2022

Registration date

01/07/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/07/2025

Last transaction

01/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/31/2024

First use in commerce

01/31/2024

Drawing code

4

Owner type

99

Owner location

Indianapolis, IN

Examiner

RINKER, ANTHONY

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Indiana Hemophilia and Thrombosis Center, Inc.

Representatives

Thomas A. Walsh ICE MILLER LLP

Technical classification

Nice Classes

Class 35Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail specialty pharmacy services; business administration of reimbursement programs for pharmaceutical services

Class 44

Pharmaceutical servicesspecialty pharmacy compounding and dispensing; preparation of prescriptions by pharmacists; preparation of prescriptions in pharmacies; providing informationadvisoryconsultancy services relating to all the aforesaid services

Publications

History of USPTO decisions and trademark events.

31 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/07/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/12/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/12/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/15/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

11/15/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/29/2024

IUAF

USE AMENDMENT FILED

08/16/2024

DRRR

DIVISIONAL REQUEST RECEIVED

08/16/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

08/16/2024

EISU

TEAS STATEMENT OF USE RECEIVED

08/16/2024

EEXT

SOU TEAS EXTENSION RECEIVED

08/15/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/05/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/09/2024

PUBO

PUBLISHED FOR OPPOSITION

01/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/20/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/30/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

11/30/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/30/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

11/30/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/30/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/30/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/30/2023

ALIE

ASSIGNED TO LIE

11/28/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/23/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/13/2023

GNRT

NON-FINAL ACTION E-MAILED

06/13/2023

CNRT

NON-FINAL ACTION WRITTEN

06/13/2023

DOCK

ASSIGNED TO EXAMINER

06/12/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/14/2022

NWAP

NEW APPLICATION ENTERED

08/29/2022

Continuous trademark protection

Get notified about every new filing that threatens INDIANA BLOODWORX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.